Kacsmaryk’s April 7 ruling was a response to a request from the plaintiffs to pause access to mifepristone while the case proceeds.

But this lawsuit, filed by a coalition of anti-abortion groups called the Alliance for Hippocratic Medicine, seeks to overturn the FDA’s approval of mifepristone, which applies nationwide. The suit alleges that the agency did not adequately evaluate mifepristone’s safety before it greenlighted the drug in 2000, and it argues that the FDA should not have made the medication accessible via telehealth.

เว็บคาสิโนออนไลน์